Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Receivables (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Receivables for 16 consecutive years, with $456.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables rose 24.68% to $456.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $456.1 million, a 24.68% increase, with the full-year FY2025 number at $456.1 million, up 24.68% from a year prior.
  • Receivables was $456.1 million for Q4 2025 at Acadia Healthcare Company, up from $452.8 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $456.1 million in Q4 2025 to a low of $283.0 million in Q1 2021.
  • A 5-year average of $364.8 million and a median of $361.6 million in 2023 define the central range for Receivables.
  • Peak YoY movement for Receivables: fell 20.01% in 2021, then rose 24.68% in 2025.
  • Acadia Healthcare Company's Receivables stood at $292.1 million in 2021, then increased by 13.86% to $332.6 million in 2022, then increased by 18.77% to $395.0 million in 2023, then dropped by 7.4% to $365.8 million in 2024, then grew by 24.68% to $456.1 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Receivables are $456.1 million (Q4 2025), $452.8 million (Q3 2025), and $431.3 million (Q2 2025).